LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 0.35 | |
| Mar2024 | ₹32 Cr | -7.30 | |
| Mar2023 | ₹34 Cr | -20.24 | |
| Mar2022 | ₹43 Cr | 3.93 | |
| Mar2021 | ₹41 Cr | - | |
Compare Contingent Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹240.3 Cr | -6.1% | -13.5% | -48.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -6.1% |
-13.5% |
-48.5% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses